IXB-314

N/A

Report date: 2024/09/14 17:35:24

Base Information

Drug NameIXB-314
Drug Alias NameIXB-314
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlutamate [NMDA] receptor antagonists
TargetsGlutamate [NMDA] receptor
Therapy Area/IndicationsDepressive Disorder, Treatment-Resistant
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySingapore
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesIx Biopharma Ltd
China Registration ClassN/A

Develop Information

Active CompaniesIx Biopharma Ltd
Inactive CompaniesN/A
Active IndicationsDepressive Disorder, Treatment-Resistant
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A